Concepedia
Statistics
Publications
105
Citations
9.5K
H-Index
54
Active since
1983
Affiliations
Inserm(Current)
Université Claude Bernard Lyon 1
Centre National de la Recherche Scientifique
Hôpital Edouard Herriot
Hospices Civils de Lyon
Philippe Clézardin is an author at Inserm specializing in medicine, oncology, and metastasis.
Publications per year
1983–2023
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
S. Boissier, Mercedes Ferreras, Olivier Peyruchaud et al. · PubMed · 2000 · 573 citations
Medicine, Oncology, Pharmacology +17
Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
Pierrick G.J. Fournier, Stéphanie Filleur, Julien Guglielmi et al. · PubMed · 2002 · 571 citations
Medicine, Endocrinology, Pharmacology +15
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
Ahmed Boucharaba, Claire‐Marie Serre, Sandra Grès et al. · Journal of Clinical Investigation · 2004 · 410 citations · Full text
Medicine, Cancer Biology, Oncology +15
Ahmed Boucharaba, Claire‐Marie Serre, Sandra Grès et al. · Journal of Clinical Investigation · 2004 · 388 citations · Full text
Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.
S. Boissier, Sandrine Magnetto, Lucien Frappart et al. · PubMed · 1997 · 347 citations
1–5 of 105